Benzinga · Mar 27, 2026
XL
NYSE · XLV
Health Care Select Sector SPDR Fund
Financial Services · Asset Management
$168.16
Down-$0.65 (-0.39%)
Updated Oct 9, 2026, 4:59 AM
SID Score
6.3/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 40.18B
- P/E ratio
- —
- Dividend yield
- 1.45%
- 52-week range
- $141.05 – $176.60
- Volume
- 11.12M
- Avg. volume
- 13M
Price performance · XLV
XLV price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
XLV closed at $168.16 after 21 trading sessions, up 1.51% for the selected period.
- Last close
- $168.16
- Period change
- +1.51%
- Period low
- $165.36
- Period high
- $171.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $168.23 | $168.51 | $165.19 | $168.16 | 11.12M |
| Oct 7, 2026 | $167.869 | $170.38 | $167.43 | $168.81 | 8.88M |
| Oct 6, 2026 | $168.00 | $169.03 | $165.82 | $167.09 | 7.34M |
| Oct 5, 2026 | $166.00 | $167.78 | $165.49 | $167.37 | 7.3M |
| Oct 2, 2026 | $166.545 | $166.85 | $165.27 | $166.18 | 7.15M |
| Oct 1, 2026 | $168.145 | $168.60 | $165.83 | $166.20 | 10.03M |
| Sep 30, 2026 | $170.155 | $170.535 | $168.39 | $168.42 | 12.13M |
| Sep 29, 2026 | $170.55 | $171.54 | $168.82 | $170.73 | 8.98M |
| Sep 28, 2026 | $169.97 | $171.87 | $169.58 | $171.26 | 6.07M |
| Sep 25, 2026 | $169.94 | $170.97 | $168.67 | $170.70 | 6M |
| Sep 24, 2026 | $168.85 | $171.535 | $168.72 | $169.87 | 8.88M |
| Sep 23, 2026 | $169.925 | $171.02 | $168.19 | $168.80 | 7.44M |
| Sep 22, 2026 | $168.79 | $170.72 | $167.86 | $169.89 | 7.13M |
| Sep 21, 2026 | $167.315 | $169.53 | $166.85 | $169.01 | 7.62M |
| Sep 18, 2026 | $168.27 | $169.06 | $167.78 | $168.39 | 11.44M |
| Sep 17, 2026 | $168.44 | $169.10 | $167.76 | $168.81 | 5.84M |
| Sep 16, 2026 | $167.75 | $168.80 | $167.41 | $167.77 | 7.16M |
| Sep 15, 2026 | $167.79 | $168.20 | $166.1783 | $167.66 | 7.43M |
| Sep 14, 2026 | $168.01 | $168.77 | $167.025 | $167.75 | 9.42M |
| Sep 11, 2026 | $166.83 | $167.13 | $165.11 | $165.36 | 6.5M |
| Sep 10, 2026 | $166.50 | $167.075 | $165.58 | $165.66 | 7.94M |
Latest XLV news
The latest Smart Investors Daily articles mentioning XLV.
Stock researchCompany · Overview
Company
Market Activity
Research & News
XLV research
Overview
Company profile and research snapshot.
Company profile
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Mar 26, 2026
Energy Stocks Hunt A Streak Record Unseen Since 2013: Are They Still A Buy Now?
XLE is on 14 straight weeks of gains — the longest run in energy sector history and one week from a record no S&P 500 sector has matched since 2013. Here's what the streak means for investors
Benzinga · Mar 25, 2026
Leading And Lagging Sectors For March 25, 2026
Benzinga · Mar 24, 2026
Leading And Lagging Sectors For March 24, 2026
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
